← Back to Clinical Trials
Recruiting NCT06465251

NCT06465251 Effects of Home-based CIMT and Clinic-based CIM on Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06465251
Status Recruiting
Phase
Sponsor The Hong Kong Polytechnic University
Condition Motor Function
Study Type INTERVENTIONAL
Enrollment 96 participants
Start Date 2024-03-01
Primary Completion 2024-12-01

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Home-based CIMTClinic-based CIMTControl

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 96 participants in total. It began in 2024-03-01 with a primary completion date of 2024-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Constraint induced movement therapy (CIMT) is based on the theoretical basis that constraining the unaffected limb following injury of the brain such as stroke can help overcome learned non-use. It comprises of constraint of the unaffected limb, massed tasks practice with the affected limb and a behavioral contract known as the transfer package whereby use of the affected limb is extended to the real-world situations. home-based rehabilitation is likely to be cost-effective, and it may reduce cost for patients in terms of hospital charges and transport fares. However, one of the major problems with the existing home-based CIMT protocols is that, they used number of hours spent carrying out tasks practice as the measure of intensity of practice, and it has been argued that, such method is not clear and it does not reflect the correct intensity of practice.

Eligibility Criteria

Inclusion Criteria: * have stroke 1-2 years before * moderate disability * a score of 1 to 3 on the motor arm item of the National Institutes of Health Stroke Scale (NIHSS) * a score of 3 or more on the upper arm item of the Motor Assessment Scale (MAS) * no significant cognitive impairment (a score of ≥24 points on Minimental state examination) Exclusion Criteria: * patients with re-stroke * serious orthopaedic conditions such joint contracture, osteoarthritis and burns that will interfere with carrying out CIMT * who are receiving rehabilitation at the time of the study

Contact & Investigator

Central Contact

Shamay NG, PhD

✉ shamay.ng@polyu.edu.hk

📞 +852 2766-4889

Principal Investigator

Shamay Ng, PhD

PRINCIPAL INVESTIGATOR

The Hong Kong Polytechnic University

Frequently Asked Questions

Who can join the NCT06465251 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Motor Function. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06465251 currently recruiting?

Yes, NCT06465251 is actively recruiting participants. Contact the research team at shamay.ng@polyu.edu.hk for enrollment information.

Where is the NCT06465251 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06465251 clinical trial?

NCT06465251 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Shamay Ng, PhD at The Hong Kong Polytechnic University. The trial plans to enroll 96 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology